Dr. Arash Akhavein Mohammadi, MD

Dr. Akhavein Mohammadi practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Akhavein Mohammadi's NPI, 1154632602, was assigned on June 30, 2010. Dr. Akhavein Mohammadi graduated from Azad University in 2005. Dr. Akhavein Mohammadi holds California license A141504.

Dr. Akhavein Mohammadi's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Akhavein Mohammadi's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Akhavein Mohammadi to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Akhavein Mohammadi practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Akhavein Mohammadi's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Akhavein Mohammadi is board certified in urology by the American Board of Urology. Dmand AI has Dr. Akhavein Mohammadi's licenses on file in 3 states: California, Florida and Ohio.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney removal surgery, kidney stone disease, prostate inflammation or infection and transurethral procedures among the conditions Dr. Akhavein Mohammadi treats.

CMS data shows 569 Medicare services from Dr. Akhavein Mohammadi across 10 procedure codes in 2024, for 241 Medicare patients. Medicare paid $35,990 for them.

CMS counts 241 Medicare patients who saw Dr. Akhavein Mohammadi in 2024. The largest group is 65 to 74, with 114 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Akhavein Mohammadi's median patient age at 67, with 30% women.

In 2024, Dr. Akhavein Mohammadi wrote 619 Medicare Part D claims for 156 patients. 71% of them were for generic drugs. CMS names the drug for 540 of them, across 14 drugs with 11 or more claims each, at $118,968 in total drug cost. In 2023, CMS named 416 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Akhavein Mohammadi for performance year 2024, reported as part of a group. Dr. Akhavein Mohammadi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Akhavein Mohammadi as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 92 general payments to Dr. Akhavein Mohammadi from 26 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 68% of the total. Boston Scientific Corporation paid the most, $2,378.

Dr. Akhavein Mohammadi graduated from Azad University in 2005.

Dr. Akhavein Mohammadi is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.